Sale of assets related to Flow Cytometry & Imaging (FCI) Business Unit Acquisition will expand Cytek’s product portfolio to include imaging and menu-based application driven flow cytometry to provide ...
FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. ...
FREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the launch of ...
FREMONT, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- At CYTO 2026, the industry’s premier flow cytometry conference, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) will showcase ...
OLATHE, Kan.--(BUSINESS WIRE)--In an effort to continue providing the highest quality of laboratory services and state-of-the art technologies to our customers, FlowMetric accepted the opportunity to ...
CTKB is the leader in full spectrum flow cytometry (FSFC). In its simplest form, flow cytometry analyzes samples for the kinds of cells or particles present and studies cells to determine their ...
Cytek Biosciences, Inc. (NASDAQ:CTKB) has announced the launch of its latest innovation, the Cytek Aurora Evo system, marking a significant leap forward in flow cytometry technology. Building on the ...
FREMONT, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that it has been named “Overall BioTech Company of the Year” in the fourth annual BioTech ...
CYTO marks the public debut of the Cytek Borealis™ system, a new 7-laser flow cytometer that integrates full spectrum flow cytometry with future cellular imaging capabilities in a single system. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results